Posting of Annual Report and AGM Notice (4485B)

TIDMIMM

RNS Number : 4485B

Immupharma PLC

17 April 2012

 
 FOR IMMEDIATE RELEASE   17 April 2012

ImmuPharma plc

Annual Report and Accounts

Notice of Annual General Meeting: 23 May 2012

In accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM: IMM) (the "Company") the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2011 has been posted to shareholders.

The annual report is available, in electronic form, for download on the Company's website www.immupharma.com.

The Company's Annual General Meeting will be held on 23 May 2012 at 11:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London SW1H 0BL.

- Ends -

For further information please contact:

 
 ImmuPharma plc                        + 44 (0) 20 7152 4080 
 Dimitri Dimitriou, Chief Executive 
  Officer 
 Lisa Baderoon, Head of Investor 
  Relations                             + 44 (0) 7721 413496 
 
 Buchanan                              + 44 (0) 20 7466 5000 
 Mark Court 
 Jessica Fontaine 
 
 Panmure, Gordon & Co., NOMAD 
  & Broker                              +44 (0) 20 7459 3600 
 Andrew Burnett 
 Fred Walsh 
 
 Espirito Santo Investment Bank         +44 (0) 20 7456 9191 
 James Bromhead 
 Richard Crawley

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCSFLEFMFESESL

Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2024 to Jul 2024